Results 1 to 10 of about 76,081,297 (156)

Transcriptional Regulation of Siglec-15 by ETS-1 and ETS-2 in Hepatocellular Carcinoma Cells. [PDF]

open access: yesInt J Mol Sci, 2023
Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) has been identified as a crucial immune suppressor in human cancers, comparable to programmed cell death 1 ligand (PD-L1).
Sheng K   +6 more
europepmc   +2 more sources

Anti-Siglec-15 Antibody Prevents Marked Bone Loss after Acute Spinal Cord Injury-Induced Immobilization in Rats. [PDF]

open access: yesJBMR Plus, 2023
Peng Y   +13 more
europepmc   +1 more source

Mechanisms of tumor immune escape mediated by Siglec-15 and advances and prospects in targeted therapy

open access: yesZhongguo aizheng zazhi
Immune checkpoint blockade targeting the programmed cell death protein-1 (PD-1) and its ligand PD-L1 has revolutionized cancer immunotherapy; however, a substantial proportion of patients exhibit primary or acquired resistance, underscoring the existence
WANG Shihui, ZHENG Tianqing
doaj  

Siglec-15 Expression in Gastric Carcinoma and Its Association With Clinicopathological Variables. [PDF]

open access: yesWorld J Oncol
Al Badr S   +5 more
europepmc   +1 more source

Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer. [PDF]

open access: yesLab Invest, 2022
Shafi S   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy